CT scan

Global Pre-clinical Imaging Market Report to 2029 - Featuring Bruker, Siemens, General Electric and TriFoil Imaging Among Others - ResearchAndMarkets.com

Retrieved on: 
星期三, 十二月 14, 2022
Research, Radiology, Utilities, Optical, Energy, Other Manufacturing, Health Technology, Science, Chemicals, Plastics, Biotechnology, Manufacturing, Health, PerkinElmer, CT, R, CT scan, MRI, Molecular imaging, Optical flow, Bruker, GE, Agilent Technologies, Research, Google Images, Investment, Government, Fujifilm, Scan (company), General Electric, PAT, Growth, Milab, Region, USD, 3D ultrasound, Medical imaging

The "Pre-clinical Imaging Market Analysis by Imaging Products (Optical Imaging, CT Imaging, Multi-Modal Imaging, MRI Imaging, Ultrasound Imaging, Reagents, Services), and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pre-clinical Imaging Market Analysis by Imaging Products (Optical Imaging, CT Imaging, Multi-Modal Imaging, MRI Imaging, Ultrasound Imaging, Reagents, Services), and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • Technological developments in the area of molecular imaging is a key driver for the growth of the global pre-clinical imaging market.
  • Nevertheless, stringent guidelines governing pre-clinical research and high cost of pre-clinical imaging treatment are expected to restrain the global market growth.
  • Based on imaging products, the market is segmented into optical imaging, CT imaging, multi-modal imaging, MRI imaging, PET/SPECT imaging devices, ultrasound imaging, photoacoustic (PAT) imaging, reagents, and services.

Global Artificial Intelligence In Medical Diagnostics Global Market Report 2022: Strategic Alliances Between Healthcare Facilities and AI Solution Providers Boost Growth - ResearchAndMarkets.com

Retrieved on: 
星期五, 十二月 9, 2022
Technology, Health Technology, Health, Artificial Intelligence, Data mining, Ansoff Matrix, Radiology, SWOT, Viral Research and Diagnostic Laboratories, Medical diagnosis, Data storage, Geography, Market development, Magnetic resonance imaging, User (computing), Investment, Diagnosis, Growth, Neurology, CT scan, Hospital, Neuroradiology, USD, Risk, Medical device, Medical imaging, Cardiology

The Global Artificial Intelligence In Medical Diagnostics Market is segmented based on Technology, Diagnosis Type, Diagnostic Tool, Applications, End-Users, and Geography.

Key Points: 
  • The Global Artificial Intelligence In Medical Diagnostics Market is segmented based on Technology, Diagnosis Type, Diagnostic Tool, Applications, End-Users, and Geography.
  • The report presents a detailed Ansoff matrix analysis for the Global Artificial Intelligence In Medical Diagnostics Market.
  • The analyst analyses the Global Artificial Intelligence In Medical Diagnostics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Theralase Releases Q322 Interim Financial Statements

Retrieved on: 
星期二, 十一月 29, 2022
Toxicology, COVID-19, PHAC, CR, NRC, Studie II, TSX, CRA, Cancer, Health Canada, Risk, PDC, Safety, Bacteria, TSX Venture Exchange, Patient, Trial of the century, Non, Public Health Agency of Canada, GLP, TTSA, Good laboratory practice, News, CT scan, Biopsy, Virus, Research, Technical Service Council, National Research Council, Squamous cell carcinoma, Data analysis, Coronavirus, Animal, Severe acute respiratory syndrome coronavirus 2, UCC, FDA, Pharmaceutical industry, Vaccine

Theralase plans to commence GLP toxicology studies in animals in 4Q2022.

Key Points: 
  • Theralase plans to commence GLP toxicology studies in animals in 4Q2022.
  • Such statements include, but are not limited to, statements regarding the Company's proposed development plans with respect to Photo Dynamic Compounds and their drug formulations and a COVID-19 vaccine.
  • All forward-looking statements are made as of the date hereof and are subject to change.
  • Except as required by law, the Company assumes no obligation to update such statements.

Photonic Advances Enhance Imaging Techniques

Retrieved on: 
星期二, 十一月 29, 2022
Technology, Biotechnology, Nanotechnology, Audio, Video, Health, Radiology, Optical, Philanthropy, Oncology, Other Science, Research, Medical Devices, Foundation, Science, Magnet, ICFO, Skin, Environment, Science, Electronics, Microscopy, Shanghai Jiao Tong University, Engineering, University, DIC, Health care, Nanostructure, OCT, Student, Acquisition, Knowledge, Virtual reality, Movement, OSA, Capillary, Nanyang Technological University, History of magnetic resonance imaging, Maintenance, Silicon, Thought, MRI, Neoplasm, Optical coherence tomography, CT scan, Health, Research, Element, Publication, CT, SWH, Light, Microscope, Medical imaging, Optica

The field of imaging has benefited greatly from advances in photonics, said Majid Ebrahim-Zadeh, ICFO - Institut de Ciencies Fotoniques, Spain, and member of the 20th Anniversary Challenge Selection Committee.

Key Points: 
  • The field of imaging has benefited greatly from advances in photonics, said Majid Ebrahim-Zadeh, ICFO - Institut de Ciencies Fotoniques, Spain, and member of the 20th Anniversary Challenge Selection Committee.
  • The research being conducted by the challenge recipients strives to solve for todays pain points in imaging, including efficiency and accessibility.
  • Im trying to revolutionize existing microscopic techniques with new and advanced optical elements based on metasurfaces, explains Hu.
  • Over the last decades, the field of medical imaging has spawned several seminal inventions, including Optical Coherence Tomography (OCT), Computed Tomography (CT), ultrasound, and Magnet Resonance Imaging (MRI).

Desert Imaging Deploys densitas® intelliMammo™ A.I. Solutions for Breast Screening Services

Retrieved on: 
星期二, 十一月 29, 2022
LP, Bone density, Mammography, Hospital, Safety, Health, PET/CT, Radiology, CT scan, MRI, EQUIP, ACR, A.I, Health care, Intelligence, Breast cancer, NS, FDA, Nuclear medicine, Medical imaging, Ultrasound

solutions for digital mammography and breast screening announced that Desert Imaging has implemented the densitas IntelliMammo platform across their health system.

Key Points: 
  • solutions for digital mammography and breast screening announced that Desert Imaging has implemented the densitas IntelliMammo platform across their health system.
  • IntelliMammoprovides Desert Imaging with on-demand actionable information and streamlined workflows to establish efficient, effective, and sustainable quality assurance and compliance processes.
  • Densitas is a global leader in artificial intelligence solutions for breast cancer screening, focused on quality, safety, efficiency, and precision breast health.
  • Headquartered in El Paso, Texas, Desert Imaging Services, LP, is a privately-owned diagnostic imaging company that combines state-of-the-art technology with compassionate, quality care.

Canon Medical Launches Non-Obsolescence Program to help customers stay at forefront of care delivery

Retrieved on: 
星期一, 十一月 28, 2022
Software, Magnetism, Heart, Healthcare disparity in Massachusetts, Canon Medical Systems Corporation, Health care, Safety, Trust, Patient, Radiology, Life, Marketing, Magnetic resonance imaging, Performance, Molecular imaging, Health, CT scan, Research, Quality of life, CT, CMSU, Medical imaging, Canon

With the rapid pace of innovation at Canon, customers can now maximize technology investments, stay current on meaningful innovations, and help extend the life of their equipment with this cost-effective, non-obsolescence program.

Key Points: 
  • With the rapid pace of innovation at Canon, customers can now maximize technology investments, stay current on meaningful innovations, and help extend the life of their equipment with this cost-effective, non-obsolescence program.
  • With this new offering, customers receive software and/or hardware enhancements, including cyber-security enhanced protection to their equipment as innovation becomes available.
  • This adds to a portfolio of initiatives such as Performance Pro training guarantee to help ensure that we are a trusted partner with our customers in the care they provide.
  • At Canon Medical, we work hand-in-hand with our partners our medical, academic and research communities.

GE Healthcare and ulrich medical announce an Agreement to Offer a Branded Multi-dose Contrast Media Injector in the U.S.

Retrieved on: 
星期一, 十一月 28, 2022
Medical Supplies, Medical Devices, Health, Hospitals, Radiology, Pharmaceutical, Gesellschaft mit beschränkter Haftung, Cardiology, Active ingredient, Regulation of tobacco by the U.S. Food and Drug Administration, Agent handling, CGMP, Injection, Radiology, Iodine, Emergency department, Neurology, Record, API, Prevalence, Patient, USD, University of Washington Department of Bioengineering, Radiological Society of North America, Good manufacturing practice, Motion, Oncology, FDA, Diagnosis, Professor, Head, Cerebral angiography, Food, University, Conditional sentence, News, NYSE, Research, Radiopharmaceutical, Thomas Edison, Multimedia, RSNA, Patient safety, GE Healthcare, Insight, CT scan, Ecosystem, Congress, MDR, Medical imaging, Pharmaceutical industry, SQM

GE Healthcare has today announced an agreement with ulrich medical for a GE Healthcare branded contrast media injector in the U.S.

Key Points: 
  • GE Healthcare has today announced an agreement with ulrich medical for a GE Healthcare branded contrast media injector in the U.S.
  • The U.S. contrast media injector market is estimated to grow at 4.3 percent annuallyi between 2022-2030, attributed to its developed healthcare infrastructure and the prevalence of chronic diseases.
  • Today, the majority of contrast enhanced CT imaging involves radiology technicians filling a syringe with contrast media prior the injection procedure.
  • Marco Campione, Americas General Manager at GE Healthcare Pharmaceutical Diagnostics said: Radiology departments are focused on managing increasing demand and on conserving contrast media.

Fujifilm to Unveil New Medical Imaging Advances at the RSNA 2022 Conference

Retrieved on: 
星期一, 十一月 21, 2022
Heart, Architecture, McCormick Place, Diagnosis, Tomosynthesis, Health, Laboratory, Gastroenterology, Anatomy, Mammography, AI, Digital radiography, Hospital, RSNA, Knowledge, Acquisition, Algorithm, Spine, Radiological Society of North America, ISS, Electricity, X-ray, MRI, Artificial intelligence, CEDM, Sale, OEM, Scoliosis, Google Images, CT scan, Radiology, DBT, FDR, Lithium, CT, Nursing, FDA, Enterprise imaging, Medical imaging, Renewable energy, Innovation, Fujifilm

When healthcare professionals are trying to diagnose medical conditions, imaging can provide a more accurate picture of what is going on inside the patients body.

Key Points: 
  • When healthcare professionals are trying to diagnose medical conditions, imaging can provide a more accurate picture of what is going on inside the patients body.
  • To learn more about Fujifilms presence at RSNA 2022 and to schedule an on-site meeting, please click here.
  • Fujifilms innovative medical imaging portfolio includes solutions for digital radiography, mammography, CT, MRI, ultrasound, gastroenterology, pulmonology, endosurgery, and minimally invasive surgery.
  • The award-winning Synapse Enterprise Imaging portfolio provides healthcare professionals with the cross-departmental imaging and data access needed to deliver a complete patient record.

PDS Biotech Announces 100% Clinical Response in Cervical Cancer Patients in Preliminary Data from IMMUNOCERV Phase 2 Clinical Trial

Retrieved on: 
星期一, 十一月 14, 2022
Trial of the century, Communication, Survival, Neck, Lymph, National Cancer Institute, Type 1, CT scan, Cancer, Mayo Clinic, Disease, Radiation, PDS, Toxicity, Immunotherapy, Treatment, Vaccine, Cervical cancer, Blood, Partnership, PET, University, Neoplasm, Research, Nature, Society, MD Anderson Cancer Center, Biotechnology, COVID-19, Merck & Co., Vulvar cancer, Warfarin necrosis, NCI, Merck, MRI, Human, CD8, Sharp, Nominal interest rate, Clinical professor, Therapy, FIGO, CRT, CPI, Gamma ray, III, Risk, Infection, Merck Sharp & Dohme Federal Credit Union, PDSB, Positron emission tomography, CR, Head, SITC, Pharmaceutical industry, Medical imaging, Patient

FLORHAM PARK, N.J., Nov. 14, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, today announced that updated clinical data from the ongoing IMMUNOCERV Phase 2 clinical trial was presented during a poster session on November 11 at the 37th Annual Meeting for the Society for Immunotherapy of Cancer (SITC 2022). These data expand upon results detailed in the abstract submitted to SITC 2022 that was released to the public on November 7.

Key Points: 
  • This includes 78% (7/9) of treated patients with advanced cervical cancer (FIGO stage III or IV).
  • 100% (9/9) of patients treated with the combination of PDS0101 and CRT had a clinical response with tumor shrinkage >60% at mid-point evaluation by MRI.
  • We look forward to the continued advancement of the IMMUNOCERV Phase 2 clinical trial and the opportunity to report updated data during 2023.
  • A third Phase 2 clinical trial in first-line treatment of locally advanced cervical cancer is being led by The University of Texas MD Anderson Cancer Center.

UW–Madison To Perform the First U.S. Evaluation of GE Healthcare’s Photon Counting CT Technology with Deep Silicon Detectors

Retrieved on: 
星期一, 十一月 21, 2022
Technology, Medical Devices, Hospitals, Software, Radiology, University, Health, Data Management, Education, Oncology, Sale, Medical physics, Health, Thomas Edison, Karolinska Institute, News, Public health, CE, Patient, NYSE, Radiology, CT scan, Noise, Research, Acquisition, Doctor of Philosophy, UW, GE Healthcare, Ecosystem, Insight, University, Molecular imaging, CT, Cardiology, Neurology, Biomedical engineering, Titanium carbide, UW Health University Hospital, Medical imaging, Pharmaceutical industry, Medical device, Photon, Medicine

Photon counting detectors push CT technology forward in two major ways: better spatial resolution and better contrast resolution, shares Tim Szczykutowicz, Ph.D., associate professor radiology at the school.

Key Points: 
  • Photon counting detectors push CT technology forward in two major ways: better spatial resolution and better contrast resolution, shares Tim Szczykutowicz, Ph.D., associate professor radiology at the school.
  • We are a part of the process of evaluating and developing this unique approach to photon counting based on Deep Silicon technology.
  • UWMadison will facilitate human subject research and produce technical feedback to test and advance GE Healthcares photon counting CT technology with Deep Silicon.
  • For more information on GE Healthcares unique approach to photon counting CT with Deep Silicon, visit gehealthcare.com .